Registration for VIVA and The VEINS 2023 is open
Industry Registration opens July 18

21 Years of Endovascular Education

In 2023, VIVA and The VEINS will bring together an internationally recognized faculty who will provide attendees with an unparalleled, transformative educational experience. Session highlights include:

  • Simulator Sessions
  • Hands-On Vascular Innovation Lab
  • Blue Sky Breakfast: The VEINS Innovation Summit
  • 5 Late-Breaking Clinical Data sessions
  • Live cases from the U.S. and Germany
  • Case-based Strategies on the Frontline in the Red Theater
  • Roundtable sessions in the Blue Theater

Our Mission

VIVA is driven to improve patient care through multidisciplinary collaboration, drawing leaders from all areas of vascular care to move the field forward.

Learn more

Our Board

VIVA's board represents specialists across the spectrum of interventional cardiology, interventional radiology, vascular medicine, and vascular surgery.

See our Board of Directors and Founders

Accreditation

Click here for information on our VIVA accreditation and 2023 credit hours.

Learn More

Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA22

November 2, 2022

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final Late-Breaking Clinical Trials session at the VIVA22 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) ...

News & Updates

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA22

November 1, 2022

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of three Late-Breaking Clinical Trials sessions at the VIVA22 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional ...

News & Updates

First Round of Late-Breaking Clinical Trial Results Announced at VIVA22

November 1, 2022

LAS VEGAS, Nov. 1, 2022 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of three Late-Breaking Clinical Trials sessions at the VIVA22 conference, hosted at Wynn L ...

Official Publication

Endorsements

Virtual VIVA App

Connect. Interact. Engage. Leverage the power of the Virtual VIVA app to access conference content from the convenience of your mobile device.

Show more